BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36137305)

  • 1. Lymphomas mimicking neuroinflammatory diseases - A diagnostic conundrum worth revisiting.
    Raza SA; Raza M; Dai M; Husan A; Cotelingam J; AlHussein H
    J Neuroimmunol; 2022 Nov; 372():577970. PubMed ID: 36137305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
    Sasagawa Y; Akai T; Tachibana O; Iizuka H
    J Neurooncol; 2015 Jan; 121(1):177-83. PubMed ID: 25258254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary central nervous system lymphomas associated with chronic inflammation: diagnostic pitfalls of central nervous system lymphomas.
    Sugita Y; Masuoka J; Kameda K; Takahashi K; Kimura Y; Higaki K; Furuta T; Ohshima K
    Brain Tumor Pathol; 2020 Oct; 37(4):127-135. PubMed ID: 32627089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
    Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
    Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current strategies in the diagnosis of diffuse large B-cell lymphoma of the central nervous system.
    Baraniskin A; Deckert M; Schulte-Altedorneburg G; Schlegel U; Schroers R
    Br J Haematol; 2012 Feb; 156(4):421-32. PubMed ID: 22077417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis.
    King RL; Goodlad JR; Calaminici M; Dotlic S; Montes-Moreno S; Oschlies I; Ponzoni M; Traverse-Glehen A; Ott G; Ferry JA
    Virchows Arch; 2020 May; 476(5):647-665. PubMed ID: 31863183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rare cases of primary central nervous system anaplastic variant of diffuse large B-cell lymphoma.
    Xu T; Jia Q; Wang Y; Liu Y; Han D; Li P; Ma J; Fan L; Yan Q; Guo S; Li M; Wang Z
    Diagn Pathol; 2019 May; 14(1):45. PubMed ID: 31109360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
    Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
    Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features of primary diffuse large B-cell lymphoma of the central nervous system - strong EZH2 expression implying diagnostic and therapeutic implication.
    Guo S; Bai Q; Rohr J; Wang Y; Liu Y; Zeng K; Yu K; Zhang X; Wang Z
    APMIS; 2016 Dec; 124(12):1054-1062. PubMed ID: 27807891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
    Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
    Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3 activation is associated with cerebrospinal fluid interleukin-10 (IL-10) in primary central nervous system diffuse large B cell lymphoma.
    Mizowaki T; Sasayama T; Tanaka K; Mizukawa K; Takata K; Nakamizo S; Tanaka H; Nagashima H; Nishihara M; Hirose T; Itoh T; Kohmura E
    J Neurooncol; 2015 Sep; 124(2):165-74. PubMed ID: 26080800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary parenchymal CNS involvement by lymphoma including rare types: Follicular and EBV-positive NK/T cell lymphoma, nasal type.
    Kleinschmidt-DeMasters BK; Gilani A
    Ann Diagn Pathol; 2021 Aug; 53():151765. PubMed ID: 34147846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of tumour microenvironment and immune checkpoints in primary central nervous system diffuse large B cell lymphomas.
    Alame M; Pirel M; Costes-Martineau V; Bauchet L; Fabbro M; Tourneret A; De Oliveira L; Durand L; Roger P; Gonzalez S; Cacheux V; Rigau V; Szablewski V
    Virchows Arch; 2020 Jun; 476(6):891-902. PubMed ID: 31811434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary central nervous system lymphomas and related diseases: Pathological characteristics and discussion of the differential diagnosis.
    Sugita Y; Muta H; Ohshima K; Morioka M; Tsukamoto Y; Takahashi H; Kakita A
    Neuropathology; 2016 Aug; 36(4):313-24. PubMed ID: 26607855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of central nervous system lymphoma via cerebrospinal fluid cytology: a case report.
    Zhao H; Ma M; Zhang L; Zheng G; Lv H; Liu J; Li X; Song B; Zhang G
    BMC Neurol; 2019 May; 19(1):90. PubMed ID: 31064334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary CNS Lymphoma vs. Tumefactive Multiple Sclerosis: A Diagnostic Challenge.
    Naeem SB; Niazi F; Baig A; Sadiq H; Sattar M
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):66-68. PubMed ID: 29290197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome.
    Muñiz C; Martín-Martín L; López A; Sánchez-González B; Salar A; Almeida J; Sancho JM; Ribera JM; Heras C; Peñalver FJ; Gómez M; González-Barca E; Alonso N; Navarro B; Olave T; Sala F; Conde E; Márquez JA; Cabezudo E; Cladera A; García-Malo M; Caballero MD; Orfao A;
    Blood; 2014 Mar; 123(12):1864-9. PubMed ID: 24501214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.
    Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD
    Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GCB-type is a favorable prognostic factor in primary CNS diffuse large B-cell lymphomas.
    Marcus C; Maragkos GA; Alterman RL; Uhlmann E; Pihan G; Varma H
    J Clin Neurosci; 2021 Jan; 83():49-55. PubMed ID: 33339691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?
    Parrott AM; Haggiagi AM; Murty VV; Bhagat G; Alobeid B
    Hematol Oncol; 2020 Dec; 38(5):817-822. PubMed ID: 32639587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.